| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 86 | 2024 | 3520 | 8.170 |
Why?
|
| Mitochondrial Diseases | 29 | 2024 | 320 | 6.530 |
Why?
|
| Calcium Channels | 21 | 2021 | 622 | 5.490 |
Why?
|
| DNA, Mitochondrial | 36 | 2023 | 817 | 4.880 |
Why?
|
| Leigh Disease | 15 | 2023 | 75 | 4.640 |
Why?
|
| Oxidative Phosphorylation | 26 | 2023 | 481 | 4.470 |
Why?
|
| Mitochondrial Proteins | 32 | 2023 | 996 | 4.100 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 15 | 2020 | 154 | 3.690 |
Why?
|
| Electron Transport Complex I | 14 | 2024 | 140 | 3.410 |
Why?
|
| Calcium-Binding Proteins | 14 | 2021 | 1081 | 2.780 |
Why?
|
| Cation Transport Proteins | 11 | 2020 | 327 | 2.610 |
Why?
|
| Oxygen | 16 | 2024 | 4189 | 2.190 |
Why?
|
| Iron-Sulfur Proteins | 4 | 2024 | 82 | 2.040 |
Why?
|
| NAD | 10 | 2022 | 593 | 2.020 |
Why?
|
| Friedreich Ataxia | 3 | 2024 | 76 | 1.950 |
Why?
|
| Calcium | 20 | 2021 | 5756 | 1.810 |
Why?
|
| Metabolome | 10 | 2020 | 895 | 1.470 |
Why?
|
| NADH, NADPH Oxidoreductases | 4 | 2022 | 93 | 1.370 |
Why?
|
| NADP | 4 | 2019 | 226 | 1.280 |
Why?
|
| K562 Cells | 9 | 2023 | 634 | 1.230 |
Why?
|
| Databases, Protein | 5 | 2021 | 383 | 1.220 |
Why?
|
| HEK293 Cells | 27 | 2021 | 4204 | 1.210 |
Why?
|
| Proteome | 10 | 2023 | 1799 | 1.170 |
Why?
|
| Glycolysis | 7 | 2023 | 827 | 1.140 |
Why?
|
| Metabolic Networks and Pathways | 6 | 2018 | 783 | 1.130 |
Why?
|
| Protein Engineering | 4 | 2020 | 540 | 1.130 |
Why?
|
| Cytosol | 6 | 2020 | 901 | 1.100 |
Why?
|
| Meclizine | 4 | 2015 | 13 | 1.090 |
Why?
|
| MELAS Syndrome | 3 | 2021 | 50 | 1.090 |
Why?
|
| Neurodegenerative Diseases | 5 | 2023 | 1061 | 1.020 |
Why?
|
| Mitochondrial Myopathies | 4 | 2020 | 47 | 1.010 |
Why?
|
| Ferredoxins | 1 | 2023 | 10 | 0.940 |
Why?
|
| Genomics | 12 | 2017 | 5720 | 0.940 |
Why?
|
| Multienzyme Complexes | 3 | 2020 | 686 | 0.930 |
Why?
|
| Energy Metabolism | 12 | 2021 | 2899 | 0.910 |
Why?
|
| HeLa Cells | 14 | 2021 | 3128 | 0.900 |
Why?
|
| Lipoylation | 1 | 2023 | 72 | 0.890 |
Why?
|
| Lyases | 1 | 2022 | 41 | 0.890 |
Why?
|
| Oxidation-Reduction | 10 | 2022 | 2187 | 0.870 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 52 | 0.860 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2023 | 117 | 0.860 |
Why?
|
| Stress, Physiological | 2 | 2020 | 1403 | 0.860 |
Why?
|
| Polycythemia | 1 | 2023 | 126 | 0.850 |
Why?
|
| Protein Biosynthesis | 8 | 2024 | 2126 | 0.840 |
Why?
|
| Lactic Acid | 4 | 2024 | 1133 | 0.800 |
Why?
|
| Caenorhabditis elegans | 5 | 2024 | 1419 | 0.800 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2023 | 2752 | 0.790 |
Why?
|
| Succinates | 2 | 2019 | 83 | 0.790 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2021 | 36 | 0.790 |
Why?
|
| Oxygen Consumption | 10 | 2022 | 1869 | 0.780 |
Why?
|
| Genome, Mitochondrial | 4 | 2022 | 71 | 0.770 |
Why?
|
| Electron Transport | 7 | 2017 | 211 | 0.760 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2021 | 38 | 0.760 |
Why?
|
| Organelles | 2 | 2021 | 264 | 0.750 |
Why?
|
| RNA-Binding Proteins | 4 | 2021 | 1903 | 0.720 |
Why?
|
| RNA Precursors | 1 | 2021 | 208 | 0.710 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2021 | 544 | 0.710 |
Why?
|
| Evolution, Molecular | 5 | 2020 | 1940 | 0.710 |
Why?
|
| Chlorides | 1 | 2022 | 667 | 0.710 |
Why?
|
| Cell Line | 20 | 2020 | 15997 | 0.700 |
Why?
|
| EF Hand Motifs | 4 | 2019 | 14 | 0.700 |
Why?
|
| Cold-Shock Response | 1 | 2019 | 16 | 0.690 |
Why?
|
| Catalase | 1 | 2020 | 222 | 0.690 |
Why?
|
| Cell Nucleus | 6 | 2023 | 2969 | 0.690 |
Why?
|
| Mutation | 27 | 2023 | 29786 | 0.690 |
Why?
|
| Mice | 54 | 2024 | 81183 | 0.680 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 79 | 0.670 |
Why?
|
| Genetic Variation | 7 | 2021 | 6544 | 0.670 |
Why?
|
| Proteomics | 13 | 2020 | 3638 | 0.660 |
Why?
|
| Animals | 81 | 2024 | 168757 | 0.660 |
Why?
|
| Aminohydrolases | 2 | 2019 | 18 | 0.660 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2019 | 17 | 0.660 |
Why?
|
| Mammals | 3 | 2023 | 1143 | 0.660 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 272 | 0.650 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 528 | 0.640 |
Why?
|
| Carbon-Carbon Lyases | 1 | 2017 | 2 | 0.630 |
Why?
|
| Glycogen Storage Disease Type V | 1 | 2017 | 7 | 0.620 |
Why?
|
| Multiprotein Complexes | 4 | 2020 | 1119 | 0.620 |
Why?
|
| Ataxia | 2 | 2023 | 304 | 0.600 |
Why?
|
| Cell Respiration | 10 | 2020 | 201 | 0.600 |
Why?
|
| Humans | 148 | 2024 | 744343 | 0.600 |
Why?
|
| Sequence Analysis, DNA | 9 | 2022 | 4803 | 0.590 |
Why?
|
| Hyperoxia | 1 | 2019 | 262 | 0.590 |
Why?
|
| Shock, Septic | 1 | 2024 | 775 | 0.590 |
Why?
|
| DNA Copy Number Variations | 3 | 2023 | 1941 | 0.590 |
Why?
|
| Thermogenesis | 2 | 2019 | 435 | 0.590 |
Why?
|
| Liver | 9 | 2023 | 7474 | 0.590 |
Why?
|
| RNA Splicing | 2 | 2021 | 907 | 0.580 |
Why?
|
| Glutathione | 2 | 2022 | 589 | 0.580 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2018 | 143 | 0.570 |
Why?
|
| Carbon | 2 | 2021 | 687 | 0.570 |
Why?
|
| Neoplasm Proteins | 5 | 2018 | 3703 | 0.570 |
Why?
|
| Gluconeogenesis | 2 | 2016 | 183 | 0.570 |
Why?
|
| Gene Knockout Techniques | 5 | 2023 | 809 | 0.560 |
Why?
|
| Naphthoquinones | 1 | 2016 | 77 | 0.560 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 232 | 0.550 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 531 | 0.550 |
Why?
|
| Genome | 6 | 2022 | 1808 | 0.550 |
Why?
|
| Homeostasis | 12 | 2022 | 3340 | 0.540 |
Why?
|
| Glycine | 3 | 2016 | 671 | 0.530 |
Why?
|
| Bacteria | 2 | 2020 | 2114 | 0.530 |
Why?
|
| Manganese | 1 | 2018 | 408 | 0.530 |
Why?
|
| Vitamin B 12 | 2 | 2019 | 527 | 0.530 |
Why?
|
| Calcium Signaling | 4 | 2015 | 721 | 0.520 |
Why?
|
| Longevity | 1 | 2023 | 1070 | 0.520 |
Why?
|
| Folic Acid | 3 | 2021 | 1300 | 0.520 |
Why?
|
| Sodium Benzoate | 1 | 2014 | 15 | 0.510 |
Why?
|
| Polymorphism, Genetic | 2 | 2020 | 4328 | 0.510 |
Why?
|
| Molecular Biology | 1 | 2018 | 596 | 0.490 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 1889 | 0.490 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 290 | 0.490 |
Why?
|
| Malate Synthase | 1 | 2013 | 1 | 0.490 |
Why?
|
| Adipose Tissue, Brown | 3 | 2019 | 757 | 0.480 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2013 | 22 | 0.480 |
Why?
|
| Ethanolamines | 2 | 2015 | 158 | 0.480 |
Why?
|
| Muscle, Skeletal | 10 | 2017 | 4931 | 0.480 |
Why?
|
| Phylogeny | 4 | 2014 | 2803 | 0.480 |
Why?
|
| Gene Expression Profiling | 12 | 2018 | 9438 | 0.480 |
Why?
|
| Glucose Tolerance Test | 4 | 2020 | 1150 | 0.460 |
Why?
|
| Genes, Mitochondrial | 4 | 2020 | 61 | 0.460 |
Why?
|
| Glucose | 10 | 2023 | 4397 | 0.450 |
Why?
|
| RNA, Messenger | 10 | 2021 | 13033 | 0.450 |
Why?
|
| Models, Biological | 6 | 2017 | 9583 | 0.440 |
Why?
|
| RNA, Transfer, Met | 2 | 2014 | 14 | 0.440 |
Why?
|
| Amino Acid Sequence | 15 | 2017 | 13815 | 0.440 |
Why?
|
| Gene Targeting | 3 | 2013 | 880 | 0.440 |
Why?
|
| Galactose | 4 | 2022 | 306 | 0.430 |
Why?
|
| RNA | 3 | 2023 | 2749 | 0.430 |
Why?
|
| Reactive Oxygen Species | 5 | 2020 | 2077 | 0.430 |
Why?
|
| Disease | 3 | 2013 | 680 | 0.420 |
Why?
|
| High-Throughput Screening Assays | 3 | 2016 | 944 | 0.420 |
Why?
|
| Wolfram Syndrome | 1 | 2012 | 13 | 0.420 |
Why?
|
| Enzymes | 1 | 2013 | 266 | 0.420 |
Why?
|
| Cluster Analysis | 4 | 2017 | 2715 | 0.410 |
Why?
|
| Fibroblasts | 5 | 2022 | 4161 | 0.400 |
Why?
|
| Eukaryota | 1 | 2012 | 99 | 0.400 |
Why?
|
| Cyclooxygenase 1 | 1 | 2011 | 104 | 0.400 |
Why?
|
| Myoblasts | 4 | 2020 | 238 | 0.390 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.380 |
Why?
|
| Methyltransferases | 3 | 2024 | 367 | 0.380 |
Why?
|
| Disease Models, Animal | 12 | 2023 | 18029 | 0.380 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 436 | 0.380 |
Why?
|
| Sirolimus | 3 | 2017 | 1564 | 0.380 |
Why?
|
| Cell Hypoxia | 3 | 2023 | 675 | 0.380 |
Why?
|
| Gene Knockdown Techniques | 7 | 2021 | 1655 | 0.370 |
Why?
|
| Culture Media | 4 | 2023 | 908 | 0.360 |
Why?
|
| Mitochondrial Membranes | 5 | 2021 | 175 | 0.360 |
Why?
|
| Gene Expression Regulation | 13 | 2021 | 12072 | 0.360 |
Why?
|
| Thoracoscopy | 1 | 2011 | 178 | 0.360 |
Why?
|
| Cell Size | 1 | 2012 | 643 | 0.360 |
Why?
|
| Molecular Sequence Data | 15 | 2015 | 18111 | 0.350 |
Why?
|
| Sepsis | 1 | 2024 | 2593 | 0.350 |
Why?
|
| Muscular Diseases | 2 | 2011 | 556 | 0.350 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 941 | 0.350 |
Why?
|
| Neuraminidase | 1 | 2010 | 210 | 0.340 |
Why?
|
| Intracellular Membranes | 5 | 2017 | 390 | 0.340 |
Why?
|
| Protein Stability | 3 | 2023 | 557 | 0.340 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2019 | 80 | 0.330 |
Why?
|
| Muscle Cells | 1 | 2010 | 197 | 0.330 |
Why?
|
| Trans-Activators | 10 | 2021 | 2924 | 0.330 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2021 | 176 | 0.330 |
Why?
|
| Glycogen | 2 | 2021 | 260 | 0.330 |
Why?
|
| Ion Transport | 4 | 2020 | 320 | 0.320 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 12261 | 0.320 |
Why?
|
| Cryoelectron Microscopy | 2 | 2024 | 571 | 0.310 |
Why?
|
| Software | 3 | 2021 | 4443 | 0.310 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 249 | 0.310 |
Why?
|
| Glucose Intolerance | 3 | 2008 | 577 | 0.300 |
Why?
|
| Pleural Effusion | 1 | 2011 | 338 | 0.300 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 770 | 0.300 |
Why?
|
| Base Sequence | 13 | 2020 | 12797 | 0.300 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4253 | 0.300 |
Why?
|
| Blood Glucose | 5 | 2014 | 6256 | 0.300 |
Why?
|
| Heme | 1 | 2009 | 307 | 0.300 |
Why?
|
| Biological Products | 1 | 2016 | 860 | 0.300 |
Why?
|
| Cell Death | 3 | 2019 | 1706 | 0.290 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2019 | 198 | 0.290 |
Why?
|
| Insulin | 8 | 2015 | 6580 | 0.290 |
Why?
|
| Models, Molecular | 8 | 2020 | 5456 | 0.280 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 1416 | 0.280 |
Why?
|
| Phenotype | 9 | 2018 | 16365 | 0.280 |
Why?
|
| Coenzyme A | 2 | 2019 | 39 | 0.280 |
Why?
|
| Aging | 2 | 2023 | 8664 | 0.270 |
Why?
|
| Protein Structure, Tertiary | 5 | 2016 | 3846 | 0.270 |
Why?
|
| Open Reading Frames | 1 | 2009 | 810 | 0.270 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2012 | 437 | 0.260 |
Why?
|
| RNA Interference | 6 | 2014 | 2889 | 0.260 |
Why?
|
| Mass Spectrometry | 6 | 2021 | 2203 | 0.260 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 2109 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3920 | 0.250 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 4186 | 0.250 |
Why?
|
| Male | 53 | 2022 | 350118 | 0.250 |
Why?
|
| N-Formylmethionine | 1 | 2024 | 16 | 0.250 |
Why?
|
| Insulin Resistance | 4 | 2020 | 3864 | 0.250 |
Why?
|
| Genetic Association Studies | 2 | 2012 | 2703 | 0.240 |
Why?
|
| Cytochrome c Group | 2 | 2001 | 128 | 0.240 |
Why?
|
| Cell Membrane | 2 | 2013 | 3748 | 0.240 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2017 | 297 | 0.240 |
Why?
|
| Oxidoreductases | 3 | 2022 | 424 | 0.240 |
Why?
|
| Sulfurtransferases | 1 | 2023 | 17 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3597 | 0.230 |
Why?
|
| Lipid Peroxides | 1 | 2023 | 73 | 0.230 |
Why?
|
| Thioctic Acid | 1 | 2023 | 23 | 0.230 |
Why?
|
| Huntington Disease | 1 | 2010 | 1124 | 0.230 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 2 | 2014 | 17 | 0.230 |
Why?
|
| Fibroblast Growth Factors | 2 | 2020 | 879 | 0.230 |
Why?
|
| Glucokinase | 1 | 2023 | 103 | 0.230 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2023 | 124 | 0.230 |
Why?
|
| Binding Sites | 4 | 2023 | 6114 | 0.230 |
Why?
|
| Ribose | 1 | 2023 | 68 | 0.230 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2003 | 14 | 0.230 |
Why?
|
| Carrier Proteins | 5 | 2017 | 5021 | 0.230 |
Why?
|
| Oxyphil Cells | 1 | 2023 | 57 | 0.220 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 1912 | 0.220 |
Why?
|
| Fermentation | 1 | 2023 | 144 | 0.220 |
Why?
|
| Allergens | 1 | 2010 | 1320 | 0.220 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2020 | 555 | 0.220 |
Why?
|
| Rubredoxins | 1 | 2022 | 2 | 0.220 |
Why?
|
| Prediabetic State | 1 | 2008 | 499 | 0.220 |
Why?
|
| Cyclophilins | 1 | 2022 | 46 | 0.220 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 3798 | 0.220 |
Why?
|
| Uridine | 1 | 2023 | 146 | 0.220 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10180 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2023 | 10481 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.210 |
Why?
|
| INDEL Mutation | 1 | 2023 | 279 | 0.210 |
Why?
|
| Sequence Deletion | 2 | 2019 | 1526 | 0.210 |
Why?
|
| Membrane Proteins | 9 | 2020 | 7880 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2017 | 7729 | 0.210 |
Why?
|
| Cytochromes b | 1 | 2021 | 36 | 0.210 |
Why?
|
| Metabolomics | 3 | 2024 | 1484 | 0.200 |
Why?
|
| Cytidine Deaminase | 2 | 2022 | 252 | 0.200 |
Why?
|
| Trichomonas vaginalis | 1 | 2022 | 76 | 0.200 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2021 | 3 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2010 | 1058 | 0.200 |
Why?
|
| Methionine | 1 | 2024 | 590 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 4262 | 0.200 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2021 | 35 | 0.200 |
Why?
|
| Cardiolipins | 2 | 2020 | 88 | 0.200 |
Why?
|
| G-Quadruplexes | 1 | 2023 | 162 | 0.190 |
Why?
|
| Chromatography, Liquid | 4 | 2017 | 976 | 0.190 |
Why?
|
| Transcription Factors | 12 | 2023 | 12208 | 0.190 |
Why?
|
| Triglycerides | 2 | 2020 | 2454 | 0.190 |
Why?
|
| Twins, Monozygotic | 1 | 2022 | 458 | 0.190 |
Why?
|
| Hydroxybutyrates | 1 | 2021 | 82 | 0.190 |
Why?
|
| Exercise | 1 | 2017 | 5615 | 0.190 |
Why?
|
| Alanine | 2 | 2021 | 572 | 0.190 |
Why?
|
| Computational Biology | 4 | 2010 | 3521 | 0.190 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 898 | 0.190 |
Why?
|
| Diseases in Twins | 1 | 2022 | 449 | 0.190 |
Why?
|
| Receptors, Estrogen | 2 | 2010 | 2187 | 0.190 |
Why?
|
| Anaerobiosis | 2 | 2021 | 140 | 0.190 |
Why?
|
| Iron | 3 | 2022 | 1774 | 0.180 |
Why?
|
| Asparagine | 1 | 2020 | 122 | 0.180 |
Why?
|
| Bayes Theorem | 2 | 2021 | 2309 | 0.180 |
Why?
|
| Oligomycins | 1 | 2019 | 19 | 0.180 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 61 | 0.180 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2019 | 22 | 0.180 |
Why?
|
| Mitochondrial Encephalomyopathies | 3 | 2017 | 37 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 21827 | 0.180 |
Why?
|
| Ribosomal Proteins | 2 | 2023 | 360 | 0.180 |
Why?
|
| Homozygote | 6 | 2019 | 1785 | 0.180 |
Why?
|
| Mice, Knockout | 9 | 2021 | 14557 | 0.170 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2019 | 41 | 0.170 |
Why?
|
| Burkitt Lymphoma | 1 | 2021 | 327 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 871 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3255 | 0.170 |
Why?
|
| Protein Conformation | 4 | 2020 | 4011 | 0.170 |
Why?
|
| Neosartorya | 1 | 2018 | 1 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2020 | 1888 | 0.170 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 200 | 0.170 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 2025 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.160 |
Why?
|
| Sulfur | 1 | 2019 | 166 | 0.160 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 3848 | 0.160 |
Why?
|
| Dictyostelium | 2 | 2020 | 75 | 0.160 |
Why?
|
| Brain | 4 | 2021 | 26385 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1479 | 0.160 |
Why?
|
| Glutathione Peroxidase | 1 | 2019 | 255 | 0.160 |
Why?
|
| Protein Transport | 4 | 2013 | 1988 | 0.160 |
Why?
|
| Female | 40 | 2021 | 380194 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2017 | 1157 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 2 | 2021 | 891 | 0.160 |
Why?
|
| Mitochondria, Heart | 3 | 2015 | 247 | 0.160 |
Why?
|
| Zebrafish | 4 | 2016 | 2994 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 2 | 2017 | 1144 | 0.160 |
Why?
|
| Pheochromocytoma | 1 | 2000 | 337 | 0.160 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2017 | 19 | 0.150 |
Why?
|
| Cells, Cultured | 9 | 2017 | 19229 | 0.150 |
Why?
|
| Multigene Family | 2 | 2013 | 1102 | 0.150 |
Why?
|
| Cell Transformation, Viral | 1 | 2019 | 565 | 0.150 |
Why?
|
| Amino Acids | 1 | 2024 | 1736 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 2 | 2021 | 1041 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1116 | 0.150 |
Why?
|
| Gene Dosage | 2 | 2014 | 1252 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2012 | 11725 | 0.150 |
Why?
|
| Algorithms | 2 | 2017 | 13881 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2016 | 562 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2017 | 66 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2017 | 936 | 0.150 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3086 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2010 | 2987 | 0.150 |
Why?
|
| Bignoniaceae | 1 | 2016 | 4 | 0.150 |
Why?
|
| Ericaceae | 1 | 2016 | 4 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2019 | 365 | 0.150 |
Why?
|
| Smegmamorpha | 1 | 2016 | 21 | 0.150 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 381 | 0.140 |
Why?
|
| Proteins | 6 | 2018 | 6103 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2021 | 570 | 0.140 |
Why?
|
| Biotin | 1 | 2017 | 254 | 0.140 |
Why?
|
| Internet | 3 | 2021 | 3064 | 0.140 |
Why?
|
| Lysosomes | 1 | 2021 | 893 | 0.140 |
Why?
|
| Onium Compounds | 1 | 1996 | 31 | 0.140 |
Why?
|
| Antimycin A | 1 | 2016 | 30 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2023 | 1173 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 954 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 2018 | 463 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 377 | 0.140 |
Why?
|
| Diamines | 1 | 1996 | 59 | 0.140 |
Why?
|
| Respiration | 3 | 2021 | 1653 | 0.140 |
Why?
|
| Adult | 18 | 2021 | 214055 | 0.140 |
Why?
|
| Heterozygote | 2 | 2014 | 2804 | 0.140 |
Why?
|
| Lipids | 2 | 2020 | 3305 | 0.140 |
Why?
|
| Pedigree | 5 | 2020 | 4644 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 658 | 0.130 |
Why?
|
| Vasoconstriction | 1 | 2018 | 597 | 0.130 |
Why?
|
| Suppression, Genetic | 1 | 2016 | 196 | 0.130 |
Why?
|
| Anemia | 2 | 2019 | 1506 | 0.130 |
Why?
|
| Ion Channels | 5 | 2015 | 1056 | 0.130 |
Why?
|
| Drosophila | 1 | 2023 | 1491 | 0.130 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1169 | 0.130 |
Why?
|
| Mitochondria, Liver | 2 | 2017 | 187 | 0.130 |
Why?
|
| Substrate Specificity | 3 | 2020 | 1801 | 0.130 |
Why?
|
| Autoantigens | 1 | 2019 | 892 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2011 | 1899 | 0.130 |
Why?
|
| Hippurates | 1 | 2014 | 16 | 0.130 |
Why?
|
| Organophosphorus Compounds | 1 | 1996 | 215 | 0.130 |
Why?
|
| Food Preservatives | 1 | 2014 | 11 | 0.130 |
Why?
|
| Microelectrodes | 1 | 1996 | 303 | 0.130 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 92 | 0.130 |
Why?
|
| Rhodophyta | 1 | 2014 | 9 | 0.130 |
Why?
|
| Conserved Sequence | 2 | 2017 | 1202 | 0.130 |
Why?
|
| Trachea | 1 | 2021 | 1076 | 0.120 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2000 | 740 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 931 | 0.120 |
Why?
|
| Cell Survival | 2 | 2018 | 5882 | 0.120 |
Why?
|
| Membrane Transport Proteins | 4 | 2022 | 1028 | 0.120 |
Why?
|
| Animal Structures | 1 | 2014 | 23 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3505 | 0.120 |
Why?
|
| Catalysis | 1 | 2016 | 761 | 0.120 |
Why?
|
| Alleles | 2 | 2023 | 6933 | 0.120 |
Why?
|
| Glyoxylates | 1 | 2013 | 10 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2016 | 367 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 156 | 0.120 |
Why?
|
| Azoospermia | 1 | 2014 | 27 | 0.120 |
Why?
|
| Malates | 1 | 2013 | 33 | 0.120 |
Why?
|
| Acyl Coenzyme A | 1 | 2013 | 55 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8428 | 0.120 |
Why?
|
| DNA-Binding Proteins | 5 | 2007 | 9648 | 0.120 |
Why?
|
| Neoplasms | 2 | 2014 | 21683 | 0.120 |
Why?
|
| Body Temperature | 2 | 2016 | 777 | 0.120 |
Why?
|
| Membrane Potentials | 4 | 2010 | 1137 | 0.120 |
Why?
|
| Acetyl Coenzyme A | 1 | 2013 | 74 | 0.120 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2013 | 64 | 0.120 |
Why?
|
| Anemia, Macrocytic | 1 | 2013 | 55 | 0.120 |
Why?
|
| Adolescent | 12 | 2021 | 85781 | 0.120 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 2916 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1114 | 0.110 |
Why?
|
| RNA, Complementary | 1 | 2013 | 45 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1836 | 0.110 |
Why?
|
| DNA Primers | 3 | 2013 | 2892 | 0.110 |
Why?
|
| Yeasts | 1 | 2014 | 285 | 0.110 |
Why?
|
| Child, Preschool | 8 | 2021 | 41006 | 0.110 |
Why?
|
| Middle Aged | 15 | 2021 | 213383 | 0.110 |
Why?
|
| Riboflavin | 1 | 2013 | 108 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2013 | 2256 | 0.110 |
Why?
|
| Endonucleases | 1 | 2016 | 380 | 0.110 |
Why?
|
| Microscopy, Electron | 2 | 2016 | 2645 | 0.110 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2012 | 251 | 0.110 |
Why?
|
| Virus Replication | 1 | 2021 | 2534 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5853 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 1758 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 479 | 0.110 |
Why?
|
| Reproducibility of Results | 5 | 2016 | 19905 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 712 | 0.110 |
Why?
|
| Child | 12 | 2021 | 77709 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2020 | 23403 | 0.110 |
Why?
|
| Glucagon | 1 | 2014 | 533 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1434 | 0.110 |
Why?
|
| Glucose Clamp Technique | 3 | 2007 | 266 | 0.110 |
Why?
|
| Apoptosis | 3 | 2019 | 9727 | 0.110 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2011 | 14 | 0.110 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2011 | 22 | 0.100 |
Why?
|
| Peptides | 2 | 2017 | 4409 | 0.100 |
Why?
|
| Antiemetics | 1 | 2013 | 177 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2014 | 1682 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2023 | 15519 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2020 | 3772 | 0.100 |
Why?
|
| Biological Evolution | 2 | 2020 | 1076 | 0.100 |
Why?
|
| Biotinylation | 3 | 2017 | 179 | 0.100 |
Why?
|
| Exodeoxyribonucleases | 1 | 2013 | 180 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 852 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 1813 | 0.100 |
Why?
|
| Lentivirus | 2 | 2011 | 501 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11483 | 0.100 |
Why?
|
| Genetic Techniques | 1 | 2014 | 435 | 0.100 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 236 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1375 | 0.100 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2010 | 29 | 0.100 |
Why?
|
| Child Nutrition Disorders | 1 | 2012 | 149 | 0.090 |
Why?
|
| Research | 1 | 2019 | 1999 | 0.090 |
Why?
|
| Obesity | 5 | 2019 | 12745 | 0.090 |
Why?
|
| Hexoses | 1 | 2010 | 30 | 0.090 |
Why?
|
| Serine | 3 | 2021 | 826 | 0.090 |
Why?
|
| Antigens, Plant | 1 | 2010 | 86 | 0.090 |
Why?
|
| Kidney | 2 | 2017 | 7186 | 0.090 |
Why?
|
| Zanamivir | 1 | 2010 | 21 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 436 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1547 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2019 | 1938 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2021 | 2751 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.090 |
Why?
|
| Glycosphingolipids | 1 | 2010 | 79 | 0.090 |
Why?
|
| Carbazoles | 1 | 2011 | 226 | 0.090 |
Why?
|
| Oseltamivir | 1 | 2010 | 75 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4665 | 0.090 |
Why?
|
| Causality | 2 | 2013 | 1275 | 0.090 |
Why?
|
| Genome, Human | 2 | 2018 | 4420 | 0.090 |
Why?
|
| Virion | 1 | 2011 | 433 | 0.090 |
Why?
|
| Young Adult | 6 | 2017 | 56430 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 16689 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 851 | 0.090 |
Why?
|
| Transcription, Genetic | 6 | 2021 | 7722 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2011 | 500 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2460 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 2029 | 0.080 |
Why?
|
| Electron Transport Complex IV | 3 | 2004 | 189 | 0.080 |
Why?
|
| Case-Control Studies | 6 | 2015 | 21746 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 602 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2011 | 2255 | 0.080 |
Why?
|
| Prostaglandins | 1 | 2010 | 405 | 0.080 |
Why?
|
| Purines | 1 | 2012 | 594 | 0.080 |
Why?
|
| COS Cells | 3 | 2017 | 1161 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1832 | 0.080 |
Why?
|
| Fasting | 3 | 2012 | 1593 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1708 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1026 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 913 | 0.080 |
Why?
|
| Aged | 10 | 2023 | 163280 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1596 | 0.080 |
Why?
|
| Mutation, Missense | 4 | 2012 | 2564 | 0.080 |
Why?
|
| Propranolol | 1 | 2010 | 502 | 0.080 |
Why?
|
| Myocardium | 3 | 2000 | 4776 | 0.080 |
Why?
|
| India | 2 | 2013 | 2197 | 0.080 |
Why?
|
| Organ Specificity | 3 | 2008 | 2008 | 0.080 |
Why?
|
| Body Weight | 3 | 2016 | 4669 | 0.080 |
Why?
|
| Exons | 2 | 2012 | 2437 | 0.080 |
Why?
|
| Creatine | 1 | 2010 | 421 | 0.080 |
Why?
|
| YY1 Transcription Factor | 1 | 2007 | 60 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2007 | 6171 | 0.080 |
Why?
|
| Qb-SNARE Proteins | 1 | 2007 | 36 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 110 | 0.080 |
Why?
|
| Lipolysis | 1 | 2008 | 210 | 0.070 |
Why?
|
| Ketones | 1 | 2008 | 188 | 0.070 |
Why?
|
| Atrophy | 1 | 2012 | 1583 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.070 |
Why?
|
| Infant | 6 | 2020 | 35136 | 0.070 |
Why?
|
| Mathematics | 1 | 2008 | 728 | 0.070 |
Why?
|
| GA-Binding Protein Transcription Factor | 2 | 2004 | 46 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2014 | 5179 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 193 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2010 | 1538 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2008 | 210 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 720 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 5867 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2017 | 25625 | 0.070 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 1194 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4091 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2009 | 895 | 0.070 |
Why?
|
| DNA Replication | 1 | 2013 | 1399 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2021 | 1866 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 742 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2010 | 1539 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15540 | 0.070 |
Why?
|
| Science | 1 | 2008 | 241 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2012 | 828 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2019 | 959 | 0.070 |
Why?
|
| Gene Expression | 3 | 2020 | 7799 | 0.060 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2005 | 43 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 411 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 634 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2282 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2016 | 1736 | 0.060 |
Why?
|
| MERRF Syndrome | 1 | 2004 | 4 | 0.060 |
Why?
|
| RNA, Transfer, Phe | 1 | 2004 | 7 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2020 | 970 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2014 | 1916 | 0.060 |
Why?
|
| Adipocytes | 2 | 2012 | 1184 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2004 | 89 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 2011 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 2014 | 1732 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 1240 | 0.060 |
Why?
|
| Hypoalbuminemia | 1 | 2005 | 87 | 0.060 |
Why?
|
| DNA Fingerprinting | 1 | 2003 | 112 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2012 | 2967 | 0.060 |
Why?
|
| Kinetics | 2 | 2008 | 6473 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2005 | 188 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 627 | 0.060 |
Why?
|
| Overweight | 1 | 2014 | 2371 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 513 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| Flavins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 1414 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.050 |
Why?
|
| FMN Reductase | 1 | 2021 | 13 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1997 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2942 | 0.050 |
Why?
|
| Microtubules | 1 | 2008 | 1090 | 0.050 |
Why?
|
| Myocytes, Cardiac | 3 | 2017 | 1637 | 0.050 |
Why?
|
| Mitochondria, Muscle | 2 | 2000 | 171 | 0.050 |
Why?
|
| Rats | 6 | 2021 | 24260 | 0.050 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 8 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2010 | 1708 | 0.050 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2021 | 156 | 0.050 |
Why?
|
| Codon, Nonsense | 2 | 2013 | 281 | 0.050 |
Why?
|
| Burkholderia cenocepacia | 1 | 2020 | 3 | 0.050 |
Why?
|
| Folic Acid Antagonists | 1 | 2021 | 84 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2699 | 0.050 |
Why?
|
| tRNA Methyltransferases | 1 | 2020 | 53 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2013 | 17446 | 0.050 |
Why?
|
| Protein Binding | 1 | 2013 | 9386 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2007 | 1640 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2421 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2421 | 0.050 |
Why?
|
| Barth Syndrome | 1 | 2020 | 25 | 0.050 |
Why?
|
| Cell Communication | 1 | 2007 | 1621 | 0.050 |
Why?
|
| Cytidine | 1 | 2020 | 68 | 0.050 |
Why?
|
| Deoxyadenosines | 1 | 2019 | 27 | 0.050 |
Why?
|
| Vero Cells | 1 | 2021 | 485 | 0.040 |
Why?
|
| Cachexia | 1 | 2001 | 204 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2005 | 587 | 0.040 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2000 | 115 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2000 | 116 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2019 | 165 | 0.040 |
Why?
|
| Amino Acid Substitution | 3 | 2014 | 1791 | 0.040 |
Why?
|
| Swine | 4 | 2015 | 5917 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2849 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 1071 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 658 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2019 | 293 | 0.040 |
Why?
|
| Quadriceps Muscle | 1 | 2020 | 144 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2019 | 167 | 0.040 |
Why?
|
| Propionates | 1 | 2019 | 169 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2017 | 40561 | 0.040 |
Why?
|
| Ruthenium Compounds | 1 | 2018 | 8 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2019 | 57 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 150 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 306 | 0.040 |
Why?
|
| Point Mutation | 3 | 2013 | 1623 | 0.040 |
Why?
|
| Haploidy | 1 | 2018 | 136 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2008 | 3494 | 0.040 |
Why?
|
| Angiotensin Amide | 1 | 2017 | 4 | 0.040 |
Why?
|
| Transfection | 2 | 2004 | 5892 | 0.040 |
Why?
|
| Lysine | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Streptavidin | 1 | 2017 | 81 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2000 | 546 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2005 | 1783 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2006 | 1253 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4462 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2017 | 203 | 0.040 |
Why?
|
| Thymidine Kinase | 1 | 2017 | 290 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 698 | 0.040 |
Why?
|
| Dimerization | 1 | 2019 | 893 | 0.040 |
Why?
|
| Dogs | 2 | 2005 | 3912 | 0.040 |
Why?
|
| Australia | 1 | 2020 | 1170 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 1032 | 0.040 |
Why?
|
| Syndrome | 2 | 2017 | 3251 | 0.040 |
Why?
|
| Phospholipids | 1 | 2020 | 784 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 1085 | 0.040 |
Why?
|
| Cell Count | 1 | 2021 | 1856 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 246 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1285 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12959 | 0.030 |
Why?
|
| Diet | 1 | 2014 | 7939 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 418 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 10900 | 0.030 |
Why?
|
| Titrimetry | 1 | 2015 | 36 | 0.030 |
Why?
|
| Myoglobin | 1 | 1996 | 160 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 437 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1996 | 313 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2000 | 2031 | 0.030 |
Why?
|
| Sodium Cyanide | 1 | 2015 | 8 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2017 | 743 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1997 | 425 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2018 | 739 | 0.030 |
Why?
|
| Water | 1 | 2022 | 1395 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2003 | 3002 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2118 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 2015 | 132 | 0.030 |
Why?
|
| Biotechnology | 1 | 2017 | 281 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2001 | 3701 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 386 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2015 | 180 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2022 | 3588 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 2872 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2015 | 337 | 0.030 |
Why?
|
| Bronchi | 1 | 2018 | 840 | 0.030 |
Why?
|
| Testosterone | 1 | 2005 | 2420 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 646 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5221 | 0.030 |
Why?
|
| Muscles | 2 | 2013 | 1614 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 182 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 424 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2017 | 881 | 0.030 |
Why?
|
| Methotrexate | 1 | 2021 | 1727 | 0.030 |
Why?
|
| Amines | 1 | 2015 | 276 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2013 | 4320 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2014 | 252 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1184 | 0.030 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 2013 | 9 | 0.030 |
Why?
|
| Peroxidase | 1 | 2017 | 611 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 252 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2014 | 160 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 987 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 351 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1900 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 356 | 0.030 |
Why?
|
| Gene Components | 1 | 2013 | 29 | 0.030 |
Why?
|
| Neurons | 2 | 2010 | 9338 | 0.030 |
Why?
|
| Telomerase | 1 | 2018 | 730 | 0.030 |
Why?
|
| Phosphates | 1 | 1997 | 786 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 507 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2017 | 1100 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2015 | 488 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1730 | 0.030 |
Why?
|
| Survival | 1 | 2013 | 163 | 0.030 |
Why?
|
| Isoleucine | 1 | 2012 | 112 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2018 | 852 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2014 | 406 | 0.030 |
Why?
|
| Hepatocytes | 2 | 2013 | 1211 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2021 | 2902 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 5751 | 0.030 |
Why?
|
| Pantothenic Acid | 1 | 2011 | 18 | 0.030 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2011 | 19 | 0.030 |
Why?
|
| Iron Metabolism Disorders | 1 | 2011 | 27 | 0.030 |
Why?
|
| Iron Chelating Agents | 1 | 2013 | 139 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2505 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2014 | 880 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2015 | 4217 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2011 | 105 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1701 | 0.020 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 32 | 0.020 |
Why?
|
| Nuclear Respiratory Factors | 2 | 2001 | 19 | 0.020 |
Why?
|
| Leucine | 1 | 2012 | 561 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 413 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3271 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 13102 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3129 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 10262 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1996 | 1534 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 2839 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1912 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9734 | 0.020 |
Why?
|
| Regulon | 1 | 2010 | 69 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13695 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 1723 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 351 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1300 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 547 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2327 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 367 | 0.020 |
Why?
|
| Adiponectin | 1 | 2015 | 1100 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2013 | 705 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 393 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 2010 | 150 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 124 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7301 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
| Coronary Sinus | 1 | 2008 | 87 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 1050 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11727 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2012 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2013 | 951 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7322 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2006 | 313 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2013 | 77449 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15076 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 1792 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 13989 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2005 | 254 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 326 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 8301 | 0.020 |
Why?
|
| Macrophages | 1 | 2019 | 5655 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 1025 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 20822 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35421 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5172 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 614 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2004 | 103 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2004 | 88 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 2004 | 149 | 0.010 |
Why?
|
| Adiposity | 1 | 2014 | 1807 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2017 | 6442 | 0.010 |
Why?
|
| Family | 1 | 2014 | 3147 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 768 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2005 | 755 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2005 | 535 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 1972 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2005 | 548 | 0.010 |
Why?
|
| Inflammation | 2 | 2015 | 10638 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2005 | 641 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2005 | 415 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2634 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2012 | 12720 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2005 | 413 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14722 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 733 | 0.010 |
Why?
|
| Arsenates | 1 | 2000 | 12 | 0.010 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2000 | 20 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2000 | 75 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2000 | 45 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2000 | 92 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 494 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 9856 | 0.010 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2005 | 373 | 0.010 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 1999 | 23 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 1999 | 23 | 0.010 |
Why?
|
| Biopolymers | 1 | 2000 | 189 | 0.010 |
Why?
|
| Massachusetts | 1 | 2012 | 8663 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2000 | 408 | 0.010 |
Why?
|
| Time Factors | 2 | 2013 | 40075 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6386 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 697 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 1221 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 1312 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3200 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 1101 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 824 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1996 | 16 | 0.010 |
Why?
|
| Octoxynol | 1 | 1996 | 77 | 0.010 |
Why?
|
| Physical Conditioning, Animal | 1 | 2000 | 362 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1519 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13408 | 0.010 |
Why?
|
| Detergents | 1 | 1996 | 230 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2003 | 1431 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3279 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12354 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 1999 | 822 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 2216 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1681 | 0.010 |
Why?
|
| Eating | 1 | 2000 | 1536 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1783 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 29063 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20947 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6459 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2005 | 3523 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 3420 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 6622 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2005 | 3752 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 53288 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 72290 | 0.000 |
Why?
|